OrthoSon Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.51M

  • Investors
  • 12

OrthoSon General Information

Description

Developer of an injectable bio-structural gel implant system designed to restore disc function and relieve back pain from degeneration. The company offers a minimally invasive implant that is injected into the disc, forms a supportive scaffold, restores mechanical properties, and suppresses degeneration, enabling patients with degenerative disc disease to achieve pain relief and improved spinal stability.

Contact Information

Website
www.orthoson.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Magdalen Centre
  • Oxford Science Park
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865
Primary Industry
Therapeutic Devices
Vertical(s)
Impact Investing, HealthTech, Life Sciences
Corporate Office
  • The Magdalen Centre
  • Oxford Science Park
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OrthoSon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Oct-2025 $3.51M Completed Pre-Clinical Trials
6. Later Stage VC (Series A) 02-Dec-2021 Completed Startup
5. Grant 29-Jul-2020 Completed Startup
4. Seed Round 02-Dec-2019 Completed Startup
3. Grant 01-Apr-2019 Completed Startup
2. Seed Round 31-Oct-2016 $1.19M $1.19M Completed Startup
1. University Spin-Out 28-Sep-2015 Completed Startup
To view OrthoSon’s complete valuation and funding history, request access »

OrthoSon Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary 431,651 $0.001350 $2.94 $2.94 1x $2.94 14.78%
Ordinary 195,265 $0.001350 $0.14 $0.14 1x $0.14 6.68%
To view OrthoSon’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

OrthoSon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an injectable bio-structural gel implant system designed to restore disc function and relieve back pain fro
Therapeutic Devices
Oxford, United Kingdom
18 As of 2026

Baltimore, MD
 

Salt Lake City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OrthoSon Competitors (4)

One of OrthoSon’s 4 competitors is ReGelTec, a Venture Capital-Backed company based in Baltimore, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ReGelTec Venture Capital-Backed Baltimore, MD
DiscGenics Venture Capital-Backed Salt Lake City, UT
Spine BioPharma Venture Capital-Backed New York, NY
Mesoblast Corporation Melbourne, Australia
To view OrthoSon’s complete competitors history, request access »

OrthoSon Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

OrthoSon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4651837-A1 Spinal repair device Pending 18-Jan-2023
GB-202300746-D0 Spinal repair device Active 18-Jan-2023
GB-2626342-A Spinal repair device Active 18-Jan-2023
GB-2626342-B Spinal repair device Active 18-Jan-2023
US-20260215928-A1 Spinal repair device Pending 18-Jan-2023 A61F2/442
To view OrthoSon’s complete patent history, request access »

OrthoSon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OrthoSon Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anjost Investment Family Office Minority
Big Pi Ventures Venture Capital Minority
Fahad Alrajhi Group Venture Capital Minority
KE Partners Venture Capital Minority
Perivoli Innovations Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

OrthoSon FAQs

  • When was OrthoSon founded?

    OrthoSon was founded in 2015.

  • Where is OrthoSon headquartered?

    OrthoSon is headquartered in Oxford, United Kingdom.

  • What is the size of OrthoSon?

    OrthoSon has 18 total employees.

  • What industry is OrthoSon in?

    OrthoSon’s primary industry is Therapeutic Devices.

  • Is OrthoSon a private or public company?

    OrthoSon is a Private company.

  • What is the current valuation of OrthoSon?

    The current valuation of OrthoSon is .

  • What is OrthoSon’s current revenue?

    The current revenue for OrthoSon is .

  • How much funding has OrthoSon raised over time?

    OrthoSon has raised $19M.

  • Who are OrthoSon’s investors?

    Anjost Investment, Big Pi Ventures, Fahad Alrajhi Group, KE Partners, and Perivoli Innovations are 5 of 12 investors who have invested in OrthoSon.

  • Who are OrthoSon’s competitors?

    ReGelTec, DiscGenics, Spine BioPharma, and Mesoblast are competitors of OrthoSon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process